Tissue and Organ ProcurementTissue DonorsBrain DeathPresumed ConsentOrgan TransplantationWaiting ListsTissue and Organ HarvestingKidney TransplantationCadaverTissue BanksDeathDonor SelectionOrgan PreservationDirected Tissue DonationUnited States Health Resources and Services AdministrationTransplantationGraft SurvivalPrinciple-Based EthicsLiver TransplantationTransplantsLiving DonorsFacility Regulation and ControlHealth Care RationingHeart TransplantationUnited StatesValue-Based PurchasingGraft RejectionEnd Stage Liver DiseaseInformed ConsentLiver FailureTransplantation, HomologousRetrospective StudiesEthics, MedicalTime FactorsTreatment OutcomeRegistriesFamilyDrugs, EssentialPatient SelectionLung TransplantationLiver DiseasesImmunosuppressive AgentsMedicarePosthumous ConceptionOrgan Preservation SolutionsFacial TransplantationPurchasing, HospitalRisk FactorsProportional Hazards ModelsRisk AssessmentTissue PreservationDissectionPostoperative ComplicationsCold IschemiaBone Marrow TransplantationHistocompatibility TestingCommission on Professional and Hospital ActivitiesFinancial ManagementCyclosporinePancreas TransplantationRaffinoseTacrolimusNegotiatingIslets of Langerhans TransplantationInsurance, AccidentResource AllocationDrugs, GenericImmunosuppressionDrug CostsKidney Failure, ChronicSperm Banks